Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2015

Atypical propylthiouracil-induced ANCA-positive vasculitis: report
of a case with unusual clinical and histopathologic findings
Jamie L. Mull
Washington University School of Medicine in St. Louis

Jason F. Solus
Washington University School of Medicine in St. Louis

Misha M. Mutizwa
Washington University School of Medicine in St. Louis

Herbert C. Chiang
Washington University School of Medicine in St. Louis

Ilana S. Rosman
Washington University School of Medicine in St. Louis

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Mull, Jamie L.; Solus, Jason F.; Mutizwa, Misha M.; Chiang, Herbert C.; Rosman, Ilana S.; and Musiek, Amy,
,"Atypical propylthiouracil-induced ANCA-positive vasculitis: report of a case with unusual clinical and
histopathologic findings." Dermatology Online Journal. 21,8. . (2015).
https://digitalcommons.wustl.edu/open_access_pubs/5147

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Jamie L. Mull, Jason F. Solus, Misha M. Mutizwa, Herbert C. Chiang, Ilana S. Rosman, and Amy Musiek

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/5147

Dermatology Online Journal
UC Davis

Peer Reviewed
Title:
Atypical propylthiouracil-induced ANCA-positive vasculitis: report of a case with unusual clinical
and histopathologic findings
Journal Issue:
Dermatology Online Journal, 21(8)
Author:
Mull, Jamie L, Washington University School of Medicine; Barnes-Jewish Hospital
Solus, Jason F, Washington University School of Medicine
Mutizwa, Misha M, Washington University School of Medicine; Barnes-Jewish Hospital
Chiang, Herbert C, Washington University School of Medicine; Barnes-Jewish Hospital
Rosman, Ilana S, Washington University School of Medicine; Barnes-Jewish Hospital
Musiek, Amy, Washington University School of Medicine; Barnes-Jewish Hospital
Publication Date:
2015
Permalink:
http://escholarship.org/uc/item/3v22b88d
Keywords:
propylthiouracil, ANCA vasculitis, vasculopathy
Local Identifier:
doj_28433
Abstract:
The side effects of propylthiouracil, including cytopenia and vasculitis, are well established.
We present an interesting case in which cytopenia and cutaneous vasculopathy occurred
concomitantly in a critically ill patient. The patient was initially treated for suspected infection
until dermatologic and rheumatologic workup revealed ANCA-positivity and vasculopathy on
histopathology, most consistent with an atypical presentation of ANCA-positive vasculitis. Upon
initiation of immunosuppressive therapy, the patient’s condition rapidly improved emphasizing the
importance of early recognition of this condition.
Copyright Information:

Copyright 2015 by the article author(s). This work is made available under the
terms of the Creative Commons Attribution-NonCommercial-NoDerivs4.0 license, http://
creativecommons.org/licenses/by-nc-nd/4.0/

eScholarship provides open access, scholarly publishing
services to the University of California and delivers a dynamic
research platform to scholars worldwide.

Volume 21 Number 8
August 2015
Case presentation
Atypical propylthiouracil-induced ANCA-positive vasculitis: report of a case with unusual clinical and
histopathologic findings
Jamie L Mull MD1, Jason F Solus MD2, Misha M Mutizwa MD3, Herbert C Chiang MD1, Ilana S Rosman MD2,
Amy Musiek MD1
Dermatology Online Journal 21 (8): 9
1

Washington University School of Medicine, Division of Dermatology, and Barnes-Jewish Hospital, Saint Louis,
MO.

2

Washington University School of Medicine, Division of Dermatology and Department of Pathology and
Immunology, Saint Louis, MO.
3

Temple University School of Medicine, Department of Dermatology, and Temple University Hospital,
Philadelphia, PA.
Correspondence:
Jamie L. Mull, MD
Address: 4961 Laclede Ave #202 Saint Louis, MO 63108
Phone: 812-459-1543
E-mail: jmull@dom.wustl.edu

Abstract
The side effects of propylthiouracil, including cytopenia and vasculitis, are well established. We present an interesting case in
which cytopenia and cutaneous vasculopathy occurred concomitantly in a critically ill patient. The patient was initially treated for
suspected infection until dermatologic and rheumatologic workup revealed ANCA-positivity and vasculopathy on histopathology,
most consistent with an atypical presentation of ANCA-positive vasculitis. Upon initiation of immunosuppressive therapy, the
patient’s condition rapidly improved emphasizing the importance of early recognition of this condition.
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Introduction
Propylthiouracil (PTU), used in the treatment of hyperthyroidism, has been implicated in a variety of dermatological conditions,
most notably an anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis. Additionally, PTU-induced agranulocytosis
and pancytopenia are known to occur [1]. We present a case of a PTU-induced pancytopenia occurring concomitantly with a
clinically-consistent cutaneous ANCA-positive vasculitis with an unusual histologic presentation of vasculopathy.

Case synopsis
A 44-year-old woman with Graves’ disease treated with PTU for four years presented with a three-week history of pharyngitis,
fatigue and anorexia with a 25-pound weight loss. Her TSH level was 0.27. She was afebrile and pancytopenic. After a

hematologic workup, the pancytopenia was attributed to PTU and the drug was discontinued, although her blood cell and platelet
counts continued to decline over the next few days with a white blood cell count as low as 500, hemoglobin of 6.2 g/dL and
platelet count of 17,000. During this time, the patient developed upper eyelid edema and purpuric plaques on her forehead and
distal extremities, some of which progressed to hemorrhagic bullae (Figure 1). She was started on broad-spectrum antibiotics,
although an extensive infectious workup was negative.

Figure 1. Purpuric plaque with hemorrhagic bulla on lower extremity

A dermatology consultation was requested and the histologic examination of a skin biopsy from the right lower extremity revealed
numerous fibrin thrombi and focal vascular injury with rare neutrophils in vessel walls, compatible with vasculopathy (Figure 2,
3).

Figure 2. (Low power H&E – 100X) There are fibrin thrombi present within blood vessel lumens. Figure 3. (High power H&E – 200X) There
is focal vascular injury with fibrin thrombi and neutrophils present within the vascular wall.

Disseminated intravascular coagulation was not suspected as there was no elevation in the activated partial thromboplastin time
(27.4), only mild elevation of the INR (1.4), a normal fibrinogen level (350), and no schistocytes on peripheral blood smear. The
d-dimer level was elevated (4,999) but was considered to be an acute phase reactant. The erythrocyte sedimentation rate and Creactive protein level were elevated at 95 and 132, respectively. Urinalysis demonstrated leukocytes, red blood cells, and protein.
A serologic workup revealed ANCA positivity (1:80). The C3 level was within normal range and the C4 level was low at 7.8.
Tests for anti-nuclear antibody, anti-histone antibody, and cryoglobulins were negative.
Based on the clinical picture, a diagnosis of PTU-induced vasculitis was made despite no signs of leukocytoclastic vasculitis on
biopsy. The patient also developed respiratory failure, presumably secondary to vasculitis, and required intubation for a brief
time. She was initially treated with high-dose methylprednisolone and after four days was switched to oral prednisone 60mg daily
as her condition began to improve. The pancytopenia was treated with G-CSF. Her symptoms, purpura, and cell counts continued
to improve and she was discharged on a corticosteroid taper.

Discussion
Even though our biopsy did not demonstrate vasculitis, based on the clinical presentation and ANCA positivity, this case is best
categorized as PTU-induced vasculitis with atypical histologic findings. Propylthiouracil is the most common medication
associated with drug-induced ANCA-positive vasculitis [2]. The pathogenesis has not been elucidated, although accumulation of
the drug in neutrophils is thought to play a role [3]. The onset of symptoms is quite broad, beginning weeks to years after starting
the medication [4]. Like other small-vessel vasculitides, the presentation can be quite variable, ranging from minimal cutaneous
involvement to widespread systemic disease. It should be noted that PTU-induced vasculitis does not always involve the skin. In
fact, renal involvement is the most common finding with cutaneous involvement seen in approximately 30 % of cases [3].
Although leukocytoclastic vasculitis is the typical pattern of vascular injury in PTU-induced vasculitis, extensive intravascular
thrombosis, as is seen in our case, has been reported and may be under-recognized in cases of PTU-induced vasculitis [5,6]. This
case was unusual in that there were no features of vasculitis on histologic exam, only vasculopathy. This may be attributed to
sampling bias based on the timing or location of the skin biopsy as the primary process is understood to be a vasculitis with
secondary vasculopathic changes. Disseminated intravascular thrombosis without histologic evidence of vasculitis has been seen
in levamisole-induced vasculopathy, which is also an ANCA-mediated condition with a similar pathogenesis to PTU-induced
vasculitis [7]. Further study may confirm whether intravascular thrombosis is a common finding in other cases of PTU-induced
vasculitis. Vasculopathy may be an underreported or unusual feature of PTU-induced vasculitis, and in the proper clinical setting,
this finding should alert the physician to the diagnosis.
Patients with this condition generally do well following cessation of the anti-thyroid medication, supportive measures, and
immunosuppressive therapy [4]. Anti-neutrophil cytoplasmic antibody titers usually fall but may remain positive [3]. The impact
that the coexisting drug-induced pancytopenia may have on prognosis is unclear, although based on this patient’s clinical
improvement we would expect most to do quite well with rapid withdrawal of the causative drug. Dermatologists can be helpful
in distinguishing between infectious and inflammatory conditions in these cases; rapid recognition of PTU-associated vasculitis is
essential to minimizing complications. Our patient experienced life-threatening pancytopenia and respiratory failure and was
treated for several days with antibiotics before a dermatology consultation was requested.
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